STOCK TITAN

Omada Health (OMDA) CEO Duffy exercises 21,570 options and sells shares under 10b5-1 plan

(Neutral)
(Neutral)
Form Type
4

Rhea-AI Filing Summary

Omada Health, Inc. chief executive officer Sean P. Duffy exercised stock options covering a total of 21,570 shares of common stock at exercise prices of $8.28 and $9.18 on August 7 and 10, 2026, and sold 21,570 shares, including a weighted-average sale at $24.8075, pursuant to a 10b5-1 trading plan adopted on March 13, 2026. The filing also reports 851,659 shares of common stock held indirectly in family trusts for his family members, with beneficial ownership disclaimed except for his pecuniary interest.

Positive

  • None.

Negative

  • None.
Insider Duffy Sean P.
Role Chief Executive Officer
Sold 21,570 shs ($510K)
Approx. gross sale proceeds $510K
Approx. exercise cost $193K
Approx. pre-tax spread $317K
Type Security Shares Price Value
Exercise Stock Option (Right to Buy) F1, F4 12,942 $0.00 $0.00
Exercise Common Stock F1 12,942 $9.18 $119K
Sale Common Stock F1, F2 12,942 $24.8075 $321K
Exercise Stock Option (Right to Buy) F1, F4 5,545 $0.00 $0.00
Exercise Stock Option (Right to Buy) F1, F4 3,083 $0.00 $0.00
Exercise Common Stock F1 5,545 $8.28 $46K
Exercise Common Stock F1 3,083 $9.18 $28K
Sale Common Stock F1 4,314 $20.90 $90K
Sale Common Stock F1 4,314 $22.80 $98K
holding Common Stock F3 -- -- --
Holdings After Transaction: Stock Option (Right to Buy) — 627,840 shares (Direct); Common Stock — 411,861 shares (Direct); Common Stock — 851,659 shares (Indirect, See footnote)
Footnotes (4)
  1. F1. Transaction made pursuant to a 10b5-1 trading plan adopted by the Reporting Person on March 13, 2026.
  2. F2. This transaction was executed in multiple trades at prices ranging from $24.70 to $25.00. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
  3. F3. Held in family trusts for the benefit of the Reporting Person's family members. The Reporting Person disclaims beneficial ownership of the shares held by the family trusts except to the extent of his pecuniary interest therein.
  4. F4. 100% of the shares subject to the option are fully vested and exercisable.
Options exercised 21,570 shares Total underlying common shares from options exercised on August 7 and 10, 2026
Shares sold 21,570 shares Total Omada Health common shares sold in reported transactions
Exercise prices $8.28 and $9.18 per share Exercise or conversion prices for Stock Option (Right to Buy) positions
Weighted-average sale price $24.8075 per share Weighted-average price for 12,942 shares sold on August 10, 2026
Indirectly held shares 851,659 shares Common stock held in family trusts for Reporting Person’s family members
10b5-1 plan adoption date March 13, 2026 Date of trading plan covering the reported transactions
10b5-1 trading plan regulatory
"Transaction made pursuant to a 10b5-1 trading plan adopted by the Reporting Person"
A 10b5-1 trading plan is a pre-arranged strategy that allows company insiders to buy or sell company stock at set times, regardless of their current knowledge about the company's situation. It acts like a scheduled appointment for trading, helping prevent the appearance of impropriety or insider trading. This plan provides a way for insiders to sell or buy shares in a controlled, transparent manner, offering reassurance to investors about fair trading practices.
Stock Option (Right to Buy) financial
"security_title: Stock Option (Right to Buy) with underlying common stock"
weighted average price financial
"This transaction was executed in multiple trades... The price reported above reflects the weighted average price."
Weighted average price is the average price of a security where each trade or component is counted according to its size, so bigger trades pull the average more than smaller ones. Think of it like calculating the average cost of a grocery haul where items you bought more of have greater influence on the final per-item cost. Investors use it to understand the true average price paid or received, judge execution quality, and compare trading performance against market movement.
pecuniary interest financial
"disclaims beneficial ownership of the shares... except to the extent of his pecuniary interest therein"
beneficial ownership financial
"The Reporting Person disclaims beneficial ownership of the shares held by the family trusts"
Beneficial ownership means the person or entity that actually enjoys the benefits of owning shares or other assets — such as receiving dividends, voting rights, or price gains — even if the legal title is held in another name. For investors it matters because knowing who truly controls and profits from a company reveals who can influence decisions, exposes potential conflicts of interest or hidden concentration of power, and affects transparency and risk in the stock.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google
Add on Google
Learn about SEC filing dates

FAQ

What transactions did Omada Health (OMDA) CEO Sean P. Duffy report on this Form 4?

Sean P. Duffy reported exercising stock options for 21,570 shares of Omada Health common stock and then selling 21,570 shares. The activity occurred on August 7 and 10, 2026, and involved both derivative and non-derivative securities.

At what prices did Sean P. Duffy exercise and sell Omada Health (OMDA) shares?

He exercised options at $8.28 and $9.18 per share and sold shares at prices including $20.90, $22.80, and a weighted-average of $24.8075. One transaction’s trades ranged between $24.70 and $25.00 per share.

Were Sean P. Duffy’s Omada Health (OMDA) trades made under a 10b5-1 plan?

Yes. A footnote states the transactions were made pursuant to a 10b5-1 trading plan adopted by Sean P. Duffy on March 13, 2026. Such plans prearrange trades, limiting the informational value of their timing.

How many Omada Health (OMDA) shares are reported as held indirectly for Sean P. Duffy’s family?

The filing reports 851,659 shares of Omada Health common stock held indirectly in family trusts. Sean P. Duffy disclaims beneficial ownership of these shares except to the extent of his pecuniary interest in the trusts.

What stock options did Sean P. Duffy exercise in Omada Health (OMDA)?

He exercised fully vested Stock Options (Right to Buy) for 21,570 underlying shares at exercise prices of $8.28 and $9.18, with option expiration dates in 2031 and 2032, converting them into Omada Health common stock.

How many Omada Health (OMDA) shares did Sean P. Duffy sell on each reported date?

On August 7, 2026, he reported selling 8,628 shares in two blocks of 4,314 shares each. On August 10, 2026, he reported selling 12,942 shares at a weighted-average price of $24.8075 per share.
SEC Form 4
FORM 4UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number:3235-0287
Estimated average burden
hours per response:0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
X
Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
1. Name and Address of Reporting Person*
Duffy Sean P.

(Last)(First)(Middle)
C/O OMADA HEALTH, INC.
611 GATEWAY BLVD., SUITE 120

(Street)
SOUTH SAN FRANCISCO CALIFORNIA 94080

(City)(State)(Zip)

UNITED STATES

(Country)
2. Issuer Name and Ticker or Trading Symbol
Omada Health, Inc. [ OMDA ]
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
XDirector10% Owner
XOfficer (give title below)Other (specify below)
Chief Executive Officer
2a. Foreign Trading Symbol
3. Date of Earliest Transaction (Month/Day/Year)
08/07/2026
6. Individual or Joint/Group Filing (Check Applicable Line)
XForm filed by One Reporting Person
Form filed by More than One Reporting Person
4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year)2A. Deemed Execution Date, if any (Month/Day/Year)3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeVAmount(A) or (D)Price
Common Stock08/07/2026M(1)5,545A$8.28417,406D
Common Stock08/07/2026M(1)3,083A$9.18420,489D
Common Stock08/07/2026S(1)4,314D$20.9416,175D
Common Stock08/07/2026S(1)4,314D$22.8411,861D
Common Stock08/10/2026M(1)12,942A$9.18424,803D
Common Stock08/10/2026S(1)12,942D$24.8075(2)411,861D
Common Stock851,659ISee footnote(3)
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year)3A. Deemed Execution Date, if any (Month/Day/Year)4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year)7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeV(A)(D)Date ExercisableExpiration DateTitleAmount or Number of Shares
Stock Option (Right to Buy)$8.2808/07/2026M(1)5,545 (4)05/05/2031Common Stock5,545$0110,532D
Stock Option (Right to Buy)$9.1808/07/2026M(1)3,083 (4)02/10/2032Common Stock3,083$0530,250D
Stock Option (Right to Buy)$9.1808/10/2026M(1)12,942 (4)02/10/2032Common Stock12,942$0517,308D
Explanation of Responses:
1. Transaction made pursuant to a 10b5-1 trading plan adopted by the Reporting Person on March 13, 2026.
2. This transaction was executed in multiple trades at prices ranging from $24.70 to $25.00. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
3. Held in family trusts for the benefit of the Reporting Person's family members. The Reporting Person disclaims beneficial ownership of the shares held by the family trusts except to the extent of his pecuniary interest therein.
4. 100% of the shares subject to the option are fully vested and exercisable.
/s/ Nathan Salha, as Attorney-in-Fact for Sean P. Duffy08/11/2026
** Signature of Reporting PersonDate
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)